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journal homepage: www.elsevier .com/ locate / jva lLETTER FROM THE EDITORSThis issue contains seven articles that offer guidance for modeling
studies for health outcomes research. To ensure that good re-
search practices in modeling remain useful for all current model-
ing techniques as well as to foster the use of model-based results
to inform health care decisions, a Modeling Good Research Prac-
tices Task Force was created. The Task Force members consist of
individuals from the International Society for Pharmacoeconom-
ics and Outcomes Research (ISPOR) and the Society for Medical
Decision Making (SMDM), and the journals of both societies, Value
in Health and Medical Decision Making, agreed to publish the Task
Force reports on the same date in both journals after a period of
peer review.
Thus, the seven articles from the ISPOR-SMDM Task Force are
being published simultaneously in Value in Health and Medical De-
cision Making. Each manuscript was submitted to both journals
simultaneously. Before submission, as part of the guidance devel-
opment process, the manuscripts underwent review by a panel of
reviewers. In addition, the membership of each society was in-
vited to comment on them. The original journal submissions in-
cluded the comments of the reviewers as well as the authors’ re-
sponses to those comments.
Prior to submission, the wording of the Task Force’s recom-
mendations was approved by the leadership of ISPOR and SMDM.
For this reason, the journals agreed, prior to submission, that we
would not change or suggest changes to the wording of the rec-
ommendations. However, we did provide opportunity for peer
review of the write-up associated with the recommendations,
since often the explanation and the interpretation of recom-
mendations are as important as the content of the recommen-
dations themselves.
We assigned each manuscript to two editors, one from each
journal. We alternated roles so that, for some articles, the Value in
Health editor had the first look, while for others, theMedical Decision
Making editor did. In some cases, the editors decided to send the
manuscript out to one of the panel reviewers, a new reviewer, or
both. All manuscripts underwent one round of revision prior tofinal acceptance. Both editors signed each decision letter. While
Value in Health had a prior agreement with ISPOR to publish all the
articles submitted, and Medical Decision Making followed its usual
editorial policy regarding invited material, the editors of the two
journals collaborated at every step, and, as it happens, all deci-
sions were mutual.
After acceptance of the articles, each journal followed its usual
policies for journal style and copyediting, which may have re-
sulted in differences in formatting. The editors did not review the
proofs from the other journal, but Jaime Caro, the leader of the
Task Force, approved the proofs for both journals. The two jour-
nals also used different procedures for disclosure of conflicts of
interest.
Source of financial support: The authors have no other finan-
cial relationships to disclose.
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